ADMA Biologics Inc Sustainability Reports
ADMA Biologics, Inc. is a commercial-stage biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics. The company focuses on the treatment and prevention of infectious diseases in immunodeficient and immunocompromised patients.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG002NCK5N4
4 reports from 2016 to 2023
Company Profile
ADMA Biologics, Inc. is a commercial-stage biopharmaceutical company that develops, manufactures, and markets specialty plasma-derived biologics. The company focuses on the treatment and prevention of infectious diseases in immunodeficient and immunocompromised patients.
Reports
4 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
